175 related articles for article (PubMed ID: 19362973)
21. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Dimopoulos MA; Hamilos G; Efstathiou E; Siapkaras I; Matsouka C; Gika D; Grigoraki V; Papadimitriou C; Mitsibounas D; Anagnostopoulos N
Leuk Lymphoma; 2003 Jun; 44(6):993-6. PubMed ID: 12854900
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
23. Waldenstrom's macroglobulinaemia--a case report.
Chin NS; Teh A; Lee MK
Med J Malaysia; 1989 Jun; 44(2):167-70. PubMed ID: 2516603
[TBL] [Abstract][Full Text] [Related]
24. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
25. Waldenström's macroglobulinemia.
McKenna JA
Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
[TBL] [Abstract][Full Text] [Related]
26. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
Bladé J; Montoto S; Rosiñol L; Montserrat E
Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
[TBL] [Abstract][Full Text] [Related]
27. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine therapy in Waldenström's macroglobulinemia.
Thalhammer-Scherrer R; Geissler K; Schwarzinger I; Chott A; Gisslinger H; Knöbl P; Lechner K; Jäger U
Ann Hematol; 2000 Oct; 79(10):556-9. PubMed ID: 11100745
[TBL] [Abstract][Full Text] [Related]
29. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
[TBL] [Abstract][Full Text] [Related]
31. Gastric MALT lymphoma presenting as Waldenström's macroglobulinemia without bone marrow involvement.
Salle V; Smail A; Joly JP; Capiod JC; Gontier MF; Duhaut P; Ducroix JP
Clin Lymphoma Myeloma; 2007 Jul; 7(7):470-1. PubMed ID: 17875236
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
[TBL] [Abstract][Full Text] [Related]
33. Waldenström's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?
Deftereos S; Farmakis D; Papadogianni A; Besleme B; Diamanti-Kandarakis E; Polymeropoylos E; Georgonikou D; Aessopos A
Mult Scler; 2004 Oct; 10(5):598-600. PubMed ID: 15471380
[TBL] [Abstract][Full Text] [Related]
34. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Leblond V; Lévy V; Maloisel F; Cazin B; Fermand JP; Harousseau JL; Remenieras L; Porcher R; Gardembas M; Marit G; Deconinck E; Desablens B; Guilhot F; Philippe G; Stamatoullas A; Guibon O;
Blood; 2001 Nov; 98(9):2640-4. PubMed ID: 11675332
[TBL] [Abstract][Full Text] [Related]
36. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
Johnson SA
Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153
[TBL] [Abstract][Full Text] [Related]
37. Waldenstrom's macroglobulinemia presenting with spinal cord compression: a case report.
Al-Halabi H; Roberge D
Am J Hematol; 2006 Dec; 81(12):955-8. PubMed ID: 16888782
[TBL] [Abstract][Full Text] [Related]
38. [Waldenström's macroglobulinemia].
Brouet JC
Rev Prat; 2006 Jan; 56(1):25-30. PubMed ID: 16548246
[TBL] [Abstract][Full Text] [Related]
39. Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.
Owen RG; Johnson SA; Morgan GJ
Hematol Oncol; 2000 Jun; 18(2):41-9. PubMed ID: 10960874
[No Abstract] [Full Text] [Related]
40. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
